London, Oct. 19, 2020 (AltAfrica)-Drug giant Pfizer has already manufactured ‘several hundred thousand doses’ of the jab at its plant in Puurs, Belgium, The Mail on Sunday reports

Whizzing off the production line in thousands of tiny bottles – new footage shows the vaccine that could end the Covid-19 misery engulfing the planet.

They are being stockpiled ready to be rolled out worldwide if clinical trials are a success, and regulators deem it safe and effective.

The US drug giant hopes to make 100 million doses available this year, a figure that will be dwarfed by the 1.3 billion jabs the company aims to manufacture in 2021. 

Every patient who receives the vaccine will need two doses.

In an interview with The Mail on Sunday, Pfizer UK boss Ben Osborn says: ‘It was great to see the first vial coming off the manufacturing line. 

‘It just brought a tremendous smile to my face to see all of this work actually result in a product.’ 

Pfizer, which is working with Germany’s BioNTech, is currently running a trial on 44,000 people, and last week said it plans to apply for emergency US approval of its vaccine in November. 

That puts Pfizer in pole position in the race to launch a Covid vaccine.

Separately, Osborn said Pfizer’s laboratory in Sandwich, Kent, has unearthed drugs that could provide a potential cure for Covid-19. 

Every stage of the vaccine’s development has been closely followed around the world. Although working at a far faster speed than normal, scientists have already missed the most ambitious deadlines set earlier in the pandemic when it was hoped a vaccine could be approved by the autumn. 

It’s believed emergency approval for the Pfizer vaccine will be sought in the US in November.